Haemonetics Sets Date for Investor/Analyst Meeting

News provided by

Apr 24, 2013, 08:00 ET

BRAINTREE, Mass., April 24, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Thursday, May 16^th from 10:00 am to 3:00 pm at The Seaport Hotel in Boston, Massachusetts.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)

The agenda for the meeting includes updates on the following:

Hospital Based Blood Management Solutions / Emerging Markets
R&D Update Including Automated Whole Blood, OrthoPAT^® Advance™ and Future New Products
Commercial Value Creation & Capture (" VCC")
Operations Overview and Strategy
Guidance and Aspirational Goals

The meeting is open to analysts, shareholders, and others in the investment community by invitation. Invitations will follow shortly and attendees must register by May 3^rd. On-line registration will be utilized and instructions for registration will accompany invitations.

Other audiences are welcome to participate in the meeting via live webcast. Webcast details are posted on the following link: http://www.media-server.com/m/p/64xj58en. For more information, please contact Bryanne Salmon at (781) 356-9613 or [email protected].

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT: Investor Relations
Gerry Gould (781) 356-9402
[email protected]
Bryanne Salmon (781) 356-9613 [email protected]

SOURCE Haemonetics Corporation